HBA1 and type 2 diabetes mellitus: From the study included in almost all of them [1, 2, 5, 8–11], showed bromocriptine significantly reduced HbA1 (Hemoglobin A1C) and FPG (Fasting Plasma Glucose) in T2DM patients.